2019
DOI: 10.1021/acsmedchemlett.9b00193
|View full text |Cite
|
Sign up to set email alerts
|

Chalcone-Thiazole Hybrids: Rational Design, Synthesis, and Lead Identification against 5-Lipoxygenase

Abstract: A hybrid pharmacophore approach is used to design and synthesize novel chalcone-thiazole hybrid molecules. Herein, thiazole has been hybridized with chalcone to obtain a new class of 5-LOX inhibitors. In vitro biological evaluation showed that most of the compounds were better 5-LOX inhibitors than the positive control, Zileuton (IC 50 = 1.05 ± 0.03 μM). The best compounds in the series, namely, 4k, 4n, and 4v (4k: IC 50 = 0.07 ± 0.02 μM, 4n: IC 50 = 0.08 ± 0.05 μM, 4v: 0.12 ± 0.04 μM) are found to be 10 times… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(15 citation statements)
references
References 25 publications
0
15
0
Order By: Relevance
“…Chalcone derivatives showed good antiviral activity ( Sinha, et al, 2019 ). For example, compound 7 ( Figure 4 ) showed 55.6, 71.2 and 92.4% of curative, protective, and inactivating activities against TMV, respectively.…”
Section: Antiviral Active Compoundsmentioning
confidence: 99%
“…Chalcone derivatives showed good antiviral activity ( Sinha, et al, 2019 ). For example, compound 7 ( Figure 4 ) showed 55.6, 71.2 and 92.4% of curative, protective, and inactivating activities against TMV, respectively.…”
Section: Antiviral Active Compoundsmentioning
confidence: 99%
“…LTs are thought to be crucial mediators of allergy and in ammatory diseases [18,19] . Until now, the only approved treatment for asthma is zileuton, a 5-LOX inhibitor, but its side effects include hepatotoxicity and poor pharmacokinetics [17] .…”
Section: Introductionmentioning
confidence: 99%
“…Thiazole–chalcone hybrids have been previously reported with promising antimicrobial [ 58 ], anticancer [ 24 ] and lipoxygenase (5-LOX) inhibitory [ 59 ] activities. In view of the above facts, we designed, synthesized and evaluated the antitubercular, antiproliferative and cytotoxic activities of 20 novel thiazole–chalcone hybrids ( 1 – 20 ) containing biologically active thiazole and chalcone pharmacophores in order to find novel lead molecules with improved biological activities ( Figure 2 ).…”
Section: Introductionmentioning
confidence: 99%